Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Clinical trial NCT03525886 · COMPLETED
Trial details
- NCT number
- NCT03525886
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2020-04-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.